Technical Analysis for PSTI - Pluristem Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 4.29 0.23% 0.01
PSTI closed up 0.23 percent on Wednesday, September 18, 2019, on 54 percent of normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical PSTI trend table...

Date Alert Name Type % Chg
Overbought Stochastic Strength 0.00%
50 DMA Resistance Bearish 0.23%
Stochastic Sell Signal Bearish 0.23%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.23%
Weak + Overbought Other 0.23%
Outside Day Range Expansion 0.23%
Overbought Stochastic Strength 0.23%
Upper Bollinger Band Touch Strength 0.23%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.38%
Weak + Overbought Other -1.38%

Older signals for PSTI ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Pluristem Therapeutics Inc., a bio-therapeutics company, engages in the research, development, and commercialization of standardized cell therapy products and related technologies for the treatment of life threatening diseases. The company's products are derived from human placenta that is a non-controversial, non-embryonic, and adult cell source. Its Placental adherent stromal cells are grown in the company's proprietary PluriX three-dimensional process that allows cells to grow in a natural environment. The company develops placenta expanded cells (PLX) and peripheral artery disease cells, an allogeneic therapeutic product that is in Phase-II clinical trials for the treatment of intermittent claudication, critical limb ischemia, and Buerger's disease. Its PLX product is developed for the treatment of muscle injury, bone marrow diseases, inflammatory bowel disease, and multiple sclerosis, as well as for pulmonary disorders, acute radiation syndrome, acute myocardial infarction, diabetic diastolic heart failure, neuropathic pain, inflammatory bowel disease, multiple sclerosis, and ischemic stroke for which the product is in various pre-clinical trials. Pluristem Therapeutics Inc. is also involved in the development and commercialization of a PLX cell-based product for the treatment of pulmonary arterial hypertension through its license agreement with the United Therapeutics Corporation. The company was formerly known as Pluristem Life Systems Inc. and changed its name to Pluristem Therapeutics Inc. in November 2007. Pluristem Therapeutics Inc. was founded in 2001 and is headquartered in Haifa, Israel.
Biotechnology Life Sciences Biology Diseases Pain Stem Cells Radiation Multiple Sclerosis Inflammatory Bowel Disease Cell Therapy Pulmonary Arterial Hypertension Peripheral Artery Disease Acute Myocardial Infarction Ischemic Stroke
Is PSTI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 13.5
52 Week Low 3.24
Average Volume 93,165
200-Day Moving Average 7.3202
50-Day Moving Average 4.5453
20-Day Moving Average 3.9452
10-Day Moving Average 4.21
Average True Range 0.2724
ADX 23.86
+DI 28.2932
-DI 14.4036
Chandelier Exit (Long, 3 ATRs ) 3.7727
Chandelier Exit (Short, 3 ATRs ) 4.2772
Upper Bollinger Band 4.5365
Lower Bollinger Band 3.3539
Percent B (%b) 0.79
BandWidth 29.975667
MACD Line -0.03
MACD Signal Line -0.1335
MACD Histogram 0.1035
Fundamentals Value
Market Cap 418.16 Million
Num Shares 97.5 Million
EPS -0.32
Price-to-Earnings (P/E) Ratio -13.41
Price-to-Sales 0.00
Price-to-Book 6.15
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.56
Resistance 3 (R3) 4.57 4.50 4.52
Resistance 2 (R2) 4.50 4.43 4.49 4.50
Resistance 1 (R1) 4.39 4.39 4.45 4.38 4.48
Pivot Point 4.32 4.32 4.34 4.31 4.32
Support 1 (S1) 4.21 4.25 4.27 4.20 4.10
Support 2 (S2) 4.14 4.21 4.13 4.08
Support 3 (S3) 4.03 4.14 4.07
Support 4 (S4) 4.02